Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06940076Phase 2Completed
Phase 2, open-label, single-arm trial in Skin aging. Primary endpoints: Glogau scale examination at 8 weeks, Skin analyzer examination at 8 weeks and 1 more. Started Mar 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06940076.